Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
November 21 2022 - 5:07PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO SECTION 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
November 9, 2022
001-36686
(Commission file number)
Forward Pharma A/S
(Translation of registrant’s name into English)
Østergade 24A, 1st Floor
1100 Copenhagen K, Denmark
(Address of principal executive office)
________________________________________
Indicate by check mark whether the registrant files or will file annual reports under cover
of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(1): Yes ☐ No ☒
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7): Yes ☐ No ☒
Indicate by check mark whether by furnishing the information contained in this Form, the registrant
is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes
☐ No ☒
If “Yes” is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g3-2(b): N/A
On November 21, 2022, Forward Pharma A/S (the “Company”) made
available on its website Amended and Restated Articles of Association, dated November 9, 2022, which were filed with the Danish Business
Authority on November 14, 2022. The Amended and Restated Articles of Association reflect changes due to the exercise of warrants.
The Company has filed as an exhibit to this Form 6-K the Amended and Restated
Articles of Association, dated November 9, 2022.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: November 21, 2022 |
|
Forward Pharma A/S |
|
|
|
|
By: |
/s/ Claus Bo Svendsen |
|
|
Name: Claus Bo Svendsen |
|
|
Title: Chief Executive Officer |
EXHIBIT INDEX
Forward Pharma AS (NASDAQ:FWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Forward Pharma AS (NASDAQ:FWP)
Historical Stock Chart
From Jul 2023 to Jul 2024